3KC3

MK2 complexed to inhibitor N4-(7-(benzofuran-2-yl)-1H-indazol-5-yl)pyrimidine-2,4-diamine

Summary for 3KC3

• Entry DOI: 10.2210/pdb3kc3/pdb
• Related: 3KA0
• Descriptor: MAP kinase-activated protein kinase 2, N~4~-[7-(1-benzofuran-2-yl)-1H-indazol-5-yl]pyrimidine-2,4-diamine (3 entities in total)
• Functional Keywords: mapkap-k2, mk2, tnfalpha, diaminopyrimidine, atp-binding, kinase, nucleotide-binding, phosphoprotein, serine/threonine-protein kinase, transferase
• Biological source: Homo sapiens (human)
• Total number of polymer chains: 12
• Total formula weight: 454021.88

Authors

Argiriadi, M.A.,Talanian, R.V.,Borhani, D.W. (deposition date: 2009-10-20, release date: 2010-01-12, Last modification date: 2024-02-21)

• Primary citation: Argiriadi, M.A.,Ericsson, A.M.,Harris, C.M.,Banach, D.L.,Borhani, D.W.,Calderwood, D.J.,Demers, M.D.,Dimauro, J.,Dixon, R.W.,Hardman, J.,Kwak, S.,Li, B.,Mankovich, J.A.,Marcotte, D.,Mullen, K.D.,Ni, B.,Pietras, M.,Sadhukhan, R.,Sousa, S.,Tomlinson, M.J.,Wang, L.,Xiang, T.,Talanian, R.V.; 2,4-Diaminopyrimidine MK2 inhibitors. Part I: Observation of an unexpected inhibitor binding mode.; Bioorg.Med.Chem.Lett., 20:330-333, 2010; PubMed: 19919896; DOI: 10.1016/j.bmcl.2009.10.102

Experimental method

X-RAY DIFFRACTION (2.9 Å)